Home Page

  • Vanderbilt University

    Study identifies key regulator of melanoma development

    Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read More

    Jun. 15, 2023

  • Vanderbilt University

    Source Material for Fluorine in Protein Chemistry

    Source material and recommended further reading related to “Fluorine in Protein Chemistry: Going Where Mother Nature Deigned to Go” by Chuck Sanders. CF2H, a Hydrogen Bond Donor J Am Chem Soc. 2017 139:9325-9332. doi: 10.1021/jacs.7b04457. Epub 2017 Jun 27. Chanan D Sessler,… Read More

    May. 12, 2023

  • Vanderbilt University

    Taking One for The Team to Defeat Rider #4 of The Apocalypse: Tackling Microbial Multi-Drug Resistance

    Adobe Stock (by Michael) by Chuck Sanders The discovery and development of antibiotics is credited with extending the average lifespan of humans by years. The golden age of antibiotic discovery spanned the late 1930s to the early 1960s, a period during which a majority of the roughly 25… Read More

    Apr. 18, 2023

  • Giving Day 2023!

    Giving Day 2023!

      THE BASICS Giving Day is an annual, 24-hour fundraising campaign providing an opportunity for Commodores across the globe to come together to show their Commodore pride and support Vanderbilt students and faculty. Gifts of all sizes will come together to provide important funding for areas across the university. Read More

    Apr. 1, 2023